Membrane transport of folates

被引:319
作者
Matherly, LH [1 ]
Goldman, D
机构
[1] Wayne State Univ, Sch Med, Expt & Clin Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA
来源
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 66 | 2003年 / 66卷
关键词
D O I
10.1016/S0083-6729(03)01012-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chapter reviews the current understanding of the transport mechanisms for folates in mammalian cells-their molecular identities and organization, tissue expression, regulation, structures, and their kinetic and thermodynamic properties. This encompasses a variety of diverse processes. Best characterized is the reduced folate carrier, a member of the SLC19 family of facilitative carriers. But other facilitative organic anion carriers (SLC21), largely expressed in epithelial tissues, transport folates as well. In addition to these bi-directional carrier systems are the membrane-localized folate receptors alpha and beta, that mediate folate uptake unidirectionally into cells via an endocytotic process. There are also several transporters, typified by the family of multidrug resistance-associated proteins, that unidirectionally export folates from cells. There are transport activities for folates, that function optimally at low pH, related in part to the reduced folate carrier, with at least one activity that is independent of this carrier. The reduced folate carrier-associated low-pH route mediates intestinal folate transport. This review considers how these different transport processes contribute to the generation of transmembrane folate gradients and to vectorial flows of folates across epithelia. The role of folate transporters in mouse development, as assessed by homologous deletion of folate receptors and the reduced folate carrier, is described. Much of the focus is on antifolate cancer chemotherapeutic agents that are often model surrogates for natural folates in transport studies. In particular, antifolate transport mediated by the reduced folate carrier is a major determinant of the activity of, and resistance to, these agents. Finally, many of the key in vitro findings on the properties of antifolate transporters are now beginning to be extended to patient specimens, thus setting the stage for understanding response to these drugs in the clinical setting at the molecular level.© 2003, Elsevier Science (USA). © 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:403 / 456
页数:54
相关论文
共 264 条
[1]   LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers [J].
Abe, T ;
Unno, M ;
Onogawa, T ;
Tokui, T ;
Kondo, TN ;
Nakagomi, R ;
Adachi, H ;
Fujiwara, K ;
Okabe, M ;
Suzuki, T ;
Nunoki, K ;
Sato, E ;
Kakyo, M ;
Nishio, T ;
Sugita, J ;
Asano, N ;
Tanemoto, M ;
Seki, M ;
Date, F ;
Ono, K ;
Kondo, Y ;
Shiiba, K ;
Suzuki, M ;
Ohtani, H ;
Shimosegawa, T ;
Iinuma, K ;
Nagura, H ;
Ito, S ;
Matsuno, S .
GASTROENTEROLOGY, 2001, 120 (07) :1689-1699
[2]   Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing [J].
Adachi, M ;
Sampath, J ;
Lan, LB ;
Sun, DX ;
Hargrove, P ;
Flatley, R ;
Tatum, A ;
Edwards, MZ ;
Wezeman, M ;
Matherly, L ;
Drake, R ;
Schuetz, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38998-39004
[3]  
Allen JD, 2002, CANCER RES, V62, P2294
[4]   POTOCYTOSIS - SEQUESTRATION AND TRANSPORT OF SMALL MOLECULES BY CAVEOLAE [J].
ANDERSON, RGW ;
KAMEN, BA ;
ROTHBERG, KG ;
LACEY, SW .
SCIENCE, 1992, 255 (5043) :410-411
[5]   Mouse folylpoly-γ-glutamate synthetase isoforms respond differently to feedback inhibition by folylpolyglutamate cofactors [J].
Andreassi, JL ;
Moran, RG .
BIOCHEMISTRY, 2002, 41 (01) :226-235
[6]   Folate receptors [J].
Antony, AC .
ANNUAL REVIEW OF NUTRITION, 1996, 16 :501-521
[7]  
ARKIN H, 1989, CANCER RES, V49, P6556
[8]   CROSS-RESISTANCE TO THE LIPID-SOLUBLE ANTIFOLATE TRIMETREXATE IN HUMAN CARCINOMA-CELLS WITH THE MULTIDRUG-RESISTANT PHENOTYPE [J].
ASSARAF, YG ;
MOLINA, A ;
SCHIMKE, RT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (04) :290-294
[9]   Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells [J].
Assaraf, YG ;
Rothem, L ;
Hooijberg, JH ;
Stark, M ;
Ifergan, I ;
Kathmann, I ;
Dijkmans, BAC ;
Peters, GJ ;
Jansen, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :6680-6686
[10]   Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells [J].
Assaraf, YG ;
Goldman, ID .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) :17460-17466